These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26735908)

  • 1. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
    George RF; Saleh DO
    Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, synthesis and 2D-QSAR study of novel vasorelaxant active benzofuran-pyridine hybrids.
    Srour AM; Abd El-Karim SS; Saleh DO; El-Eraky WI; Nofal ZM
    Bioorg Med Chem Lett; 2016 May; 26(10):2557-2561. PubMed ID: 27048942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and vasodilator activity of some pyridazin-3(2
    Allam HA; Kamel AA; El-Daly M; George RF
    Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.
    Khalifa NM; Srour AM; Abd El-Karim SS; Saleh DO; Al-Omar MA
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
    Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
    Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
    Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
    Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
    Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
    Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Molecular Modeling of Novel Substituted Pyridazinones and their Vasorelaxant Activities.
    Ismail MMF; Soliman DHS; Elmoniem MHA; Jaleel GAA
    Med Chem; 2021; 17(2):171-186. PubMed ID: 32216740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: comparison with hydralazine.
    Campos-Toimil M; Estévez I; Raviña E; Orallo F
    Gen Pharmacol; 1998 Feb; 30(2):201-7. PubMed ID: 9580127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
    Bansal R; Kumar D; Carron R; de la Calle C
    Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, ex vivo and in silico studies of 3-cyano-2-pyridone derivatives with vasorelaxant activity.
    Hernández F; Sánchez A; Rendón-Vallejo P; Millán-Pacheco C; Alcaraz Y; Delgado F; Vázquez MA; Estrada-Soto S
    Eur J Med Chem; 2013; 70():669-76. PubMed ID: 24212125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studies.
    Dong X; Wang Y; Liu T; Wu P; Gao J; Xu J; Yang B; Hu Y
    Molecules; 2011 Sep; 16(10):8257-72. PubMed ID: 21959298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives.
    Zheng CB; Gao WC; Pang PP; Ma X; Peng LC; Yang L; Li X
    Bioorg Med Chem Lett; 2021 Mar; 36():127785. PubMed ID: 33444740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
    Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.
    Gouault N; Martin-Chouly CA; Lugnier C; Cupif JF; Tonnelier A; Feger F; Lagente V; David M
    J Pharm Pharmacol; 2004 Aug; 56(8):1029-37. PubMed ID: 15285848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of n-butylphthalide derivatives.
    Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
    Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzofuran-morpholinomethyl-pyrazoline hybrids as a new class of vasorelaxant agents: synthesis and quantitative structure-activity relationship study.
    Hassan GS; Rahman DE; Abdel Saleh DO; Abdel Jaleel GA
    Chem Pharm Bull (Tokyo); 2014; 62(12):1238-51. PubMed ID: 25450632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and vasorelaxant evaluation of novel coumarin-pyrimidine hybrids.
    Amin KM; Awadalla FM; Eissa AA; Abou-Seri SM; Hassan GS
    Bioorg Med Chem; 2011 Oct; 19(20):6087-97. PubMed ID: 21908192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
    Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
    Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.